Media Hits

Researchers transformed a plant pathogen weapon into a programmable tool for DNA editing.

Naturally suppressed genes turned on by Professor Charles Gersbach lab's CRISPR technology offer cure hopes for rare diseases.

For the past decade, a research team led by Cameron McIntyre has been developing a platform to convert 2D MRI brain scans into interactive 3D holographic visualizations to assist brain surgeons.

Lingchong You's 2022 study is cited as one of the main reasons a kitchen sponge is so good at harboring a wide diversity and large density of bacteria.

Pranam Chatterjee uses generative AI to create thousands of new potential therapeutic peptides and match them to "undruggable" biomolecular targets

Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, depression, bipolar disorder, and schizophrenia.

Launched from the lab of Charles Gersbach, the company uses epigenetic editing to control gene expression without modifying the DNA itself

Amanda Randles has developed computational methods that create ultra-realistic 3D simulations of biological processes within the human body down to the cellular level.

Kafui Dzirasa advised the first study published by the African Ancestry Neuroscience Research Initiative

Charles Gersbach weighs in on the use of CRISPR to create epigenetic treatments that could hit the market by the end of the decade.

Discover the innovative spaceship-like disc that allows quick and precise tests for cancer

A CRISPR-based screening platform helped Charles Gersbach and colleagues identify a transcription factor that makes CAR T cells better at killing cancer cells.